InvestorsHub Logo
Followers 83
Posts 2557
Boards Moderated 0
Alias Born 06/15/2018

Re: None

Monday, 04/29/2019 1:05:19 PM

Monday, April 29, 2019 1:05:19 PM

Post# of 94
$MNTM Before ARJ Consulting bought Mount Tam Delaware, the medical licenses were transferred out to a newly created, corporation, Mount Tam Therapeutics. So Andrew Garnock got a nice clean subsidiary with some NOLs and tax credits for $410k -- which begs the question what he plans to do with it?

One thought is that he will use it to expand his own nano CBD venture, given his immense success with PharmaCam/Cronos. Not sure if it could tie in with Vrus just yet, but you never know.

Only 55 million shares, and lots of it owned by insiders. Tantalizing possibilities.



- - -



On October 18, 2018, the “Company” and Mount Tam Biotechnologies, Inc., a Delaware corporation, its wholly-owned Delaware subsidiary (“Mount Tam Delaware”), entered into a stock purchase agreement (the “SPA”) with ARJ Consulting, LLC, a New York limited liability company (the “Buyer”), pursuant to which the Company sold 100% of the capital stock in and of Mount Tam Delaware to the Buyer (the “Sale Transaction”).

Prior to the Sale Transaction, the Company caused Mount Tam to transfer certain assets, including the Buck Institute License Agreement, that Mount Tam Delaware was holding to another wholly-owned subsidiary of the Company, Mount Tam Therapeutics, Inc., a newly formed (October 2018) Delaware corporation. At the time of the Sale Transaction Mount Tam possessed certain Net Operating Losses and tax credits. Pursuant to the terms of the SPA, the Buyer purchased Mount Tam for a purchase price of $410,000.